Fatigue in Parkinson's Disease: Prevalence and Associated Factors
Identifieur interne : 000825 ( PascalFrancis/Corpus ); précédent : 000824; suivant : 000826Fatigue in Parkinson's Disease: Prevalence and Associated Factors
Auteurs : Antoine G. Beiske ; Jon Havard Loge ; Marianne J. Hjermstad ; Elisabeth SvenssonSource :
- Movement disorders [ 0885-3185 ] ; 2010.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
The purpose of this study was to examine the prevalence of fatigue in Parkinson's disease (PD) patients and compare this to the general population. Factors associated with fatigue were investigated by linear regression. Fatigue was assessed by the fatigue questionnaire. The mean age of the 176 PD patients (41 % women) was 69 years (range 35-90), and the mean UPDRSIII was 22.3 (SD 11.7). Fatigue levels (means) were significantly higher in PD patients compared with the general population; however, effect sizes were moderate for women for physical and total fatigue indicating clinically significant differences here only. Only female PD patients had more chronic fatigue than the general population. Fatigue was related to characteristics of PD but also to sleep disturbance, depression, and gender. This population-based study demonstrates that fatigue is a common symptom in PD patients, but compared with the general population, clinically significant differences were only found for female PD patients.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 10-0491629 INIST |
---|---|
ET : | Fatigue in Parkinson's Disease: Prevalence and Associated Factors |
AU : | BEISKE (Antoine G.); HAVARD LOGE (Jon); HJERMSTAD (Marianne J.); SVENSSON (Elisabeth) |
AF : | Department of Neurology, Akershus University Hospital/Norvège (1 aut.); Department of Oncology, National Resource Centre for Late Effects, Oslo University Hospital Montebello/Norvège (2 aut.); Department of Behavioural Sciences in Medicine, University of Oslo/Norvège (2 aut.); Department of Oncology, Regional Centre for Excellence in Palliative Care, Oslo University Hospital/Ulleval/Norvège (3 aut.); Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology/Norvège (3 aut.); Department of Adult Mental Health, Division of Mental Health, Norwegian Institute of Public Health/Norvège (4 aut.) |
DT : | Publication en série; Courte communication, note brève; Niveau analytique |
SO : | Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2010; Vol. 25; No. 14; Pp. 2456-2460; Bibl. 29 ref. |
LA : | Anglais |
EA : | The purpose of this study was to examine the prevalence of fatigue in Parkinson's disease (PD) patients and compare this to the general population. Factors associated with fatigue were investigated by linear regression. Fatigue was assessed by the fatigue questionnaire. The mean age of the 176 PD patients (41 % women) was 69 years (range 35-90), and the mean UPDRSIII was 22.3 (SD 11.7). Fatigue levels (means) were significantly higher in PD patients compared with the general population; however, effect sizes were moderate for women for physical and total fatigue indicating clinically significant differences here only. Only female PD patients had more chronic fatigue than the general population. Fatigue was related to characteristics of PD but also to sleep disturbance, depression, and gender. This population-based study demonstrates that fatigue is a common symptom in PD patients, but compared with the general population, clinically significant differences were only found for female PD patients. |
CC : | 002B17; 002B17G |
FD : | Maladie de Parkinson; Syndrome de fatigue chronique; Pathologie du système nerveux; Fatigue; Prévalence; Norvège |
FG : | Europe; Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central |
ED : | Parkinson disease; Chronic fatigue syndrome; Nervous system diseases; Fatigue; Prevalence; Norway |
EG : | Europe; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease |
SD : | Parkinson enfermedad; Fatiga crónica síndrome; Sistema nervioso patología; Fatiga; Prevalencia; Noruega |
LO : | INIST-20953.354000192780100290 |
ID : | 10-0491629 |
Links to Exploration step
Pascal:10-0491629Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Fatigue in Parkinson's Disease: Prevalence and Associated Factors</title>
<author><name sortKey="Beiske, Antoine G" sort="Beiske, Antoine G" uniqKey="Beiske A" first="Antoine G." last="Beiske">Antoine G. Beiske</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Akershus University Hospital</s1>
<s3>NOR</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Havard Loge, Jon" sort="Havard Loge, Jon" uniqKey="Havard Loge J" first="Jon" last="Havard Loge">Jon Havard Loge</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Oncology, National Resource Centre for Late Effects, Oslo University Hospital Montebello</s1>
<s3>NOR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>Department of Behavioural Sciences in Medicine, University of Oslo</s1>
<s3>NOR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hjermstad, Marianne J" sort="Hjermstad, Marianne J" uniqKey="Hjermstad M" first="Marianne J." last="Hjermstad">Marianne J. Hjermstad</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Oncology, Regional Centre for Excellence in Palliative Care, Oslo University Hospital</s1>
<s2>Ulleval</s2>
<s3>NOR</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="05"><s1>Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology</s1>
<s3>NOR</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Svensson, Elisabeth" sort="Svensson, Elisabeth" uniqKey="Svensson E" first="Elisabeth" last="Svensson">Elisabeth Svensson</name>
<affiliation><inist:fA14 i1="06"><s1>Department of Adult Mental Health, Division of Mental Health, Norwegian Institute of Public Health</s1>
<s3>NOR</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">10-0491629</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 10-0491629 INIST</idno>
<idno type="RBID">Pascal:10-0491629</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000825</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Fatigue in Parkinson's Disease: Prevalence and Associated Factors</title>
<author><name sortKey="Beiske, Antoine G" sort="Beiske, Antoine G" uniqKey="Beiske A" first="Antoine G." last="Beiske">Antoine G. Beiske</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Akershus University Hospital</s1>
<s3>NOR</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Havard Loge, Jon" sort="Havard Loge, Jon" uniqKey="Havard Loge J" first="Jon" last="Havard Loge">Jon Havard Loge</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Oncology, National Resource Centre for Late Effects, Oslo University Hospital Montebello</s1>
<s3>NOR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>Department of Behavioural Sciences in Medicine, University of Oslo</s1>
<s3>NOR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hjermstad, Marianne J" sort="Hjermstad, Marianne J" uniqKey="Hjermstad M" first="Marianne J." last="Hjermstad">Marianne J. Hjermstad</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Oncology, Regional Centre for Excellence in Palliative Care, Oslo University Hospital</s1>
<s2>Ulleval</s2>
<s3>NOR</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="05"><s1>Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology</s1>
<s3>NOR</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Svensson, Elisabeth" sort="Svensson, Elisabeth" uniqKey="Svensson E" first="Elisabeth" last="Svensson">Elisabeth Svensson</name>
<affiliation><inist:fA14 i1="06"><s1>Department of Adult Mental Health, Division of Mental Health, Norwegian Institute of Public Health</s1>
<s3>NOR</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Chronic fatigue syndrome</term>
<term>Fatigue</term>
<term>Nervous system diseases</term>
<term>Norway</term>
<term>Parkinson disease</term>
<term>Prevalence</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Maladie de Parkinson</term>
<term>Syndrome de fatigue chronique</term>
<term>Pathologie du système nerveux</term>
<term>Fatigue</term>
<term>Prévalence</term>
<term>Norvège</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The purpose of this study was to examine the prevalence of fatigue in Parkinson's disease (PD) patients and compare this to the general population. Factors associated with fatigue were investigated by linear regression. Fatigue was assessed by the fatigue questionnaire. The mean age of the 176 PD patients (41 % women) was 69 years (range 35-90), and the mean UPDRSIII was 22.3 (SD 11.7). Fatigue levels (means) were significantly higher in PD patients compared with the general population; however, effect sizes were moderate for women for physical and total fatigue indicating clinically significant differences here only. Only female PD patients had more chronic fatigue than the general population. Fatigue was related to characteristics of PD but also to sleep disturbance, depression, and gender. This population-based study demonstrates that fatigue is a common symptom in PD patients, but compared with the general population, clinically significant differences were only found for female PD patients.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>25</s2>
</fA05>
<fA06><s2>14</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Fatigue in Parkinson's Disease: Prevalence and Associated Factors</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>BEISKE (Antoine G.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>HAVARD LOGE (Jon)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>HJERMSTAD (Marianne J.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>SVENSSON (Elisabeth)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Neurology, Akershus University Hospital</s1>
<s3>NOR</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Oncology, National Resource Centre for Late Effects, Oslo University Hospital Montebello</s1>
<s3>NOR</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Behavioural Sciences in Medicine, University of Oslo</s1>
<s3>NOR</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Department of Oncology, Regional Centre for Excellence in Palliative Care, Oslo University Hospital</s1>
<s2>Ulleval</s2>
<s3>NOR</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology</s1>
<s3>NOR</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Department of Adult Mental Health, Division of Mental Health, Norwegian Institute of Public Health</s1>
<s3>NOR</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA20><s1>2456-2460</s1>
</fA20>
<fA21><s1>2010</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000192780100290</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2010 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>29 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>10-0491629</s0>
</fA47>
<fA60><s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>The purpose of this study was to examine the prevalence of fatigue in Parkinson's disease (PD) patients and compare this to the general population. Factors associated with fatigue were investigated by linear regression. Fatigue was assessed by the fatigue questionnaire. The mean age of the 176 PD patients (41 % women) was 69 years (range 35-90), and the mean UPDRSIII was 22.3 (SD 11.7). Fatigue levels (means) were significantly higher in PD patients compared with the general population; however, effect sizes were moderate for women for physical and total fatigue indicating clinically significant differences here only. Only female PD patients had more chronic fatigue than the general population. Fatigue was related to characteristics of PD but also to sleep disturbance, depression, and gender. This population-based study demonstrates that fatigue is a common symptom in PD patients, but compared with the general population, clinically significant differences were only found for female PD patients.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Syndrome de fatigue chronique</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Chronic fatigue syndrome</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Fatiga crónica síndrome</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Pathologie du système nerveux</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Fatigue</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Fatigue</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Fatiga</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Prévalence</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Prevalence</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Prevalencia</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Norvège</s0>
<s2>NG</s2>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Norway</s0>
<s2>NG</s2>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Noruega</s0>
<s2>NG</s2>
<s5>11</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Europe</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Europe</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Europa</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Pathologie du système nerveux central</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fN21><s1>326</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 10-0491629 INIST</NO>
<ET>Fatigue in Parkinson's Disease: Prevalence and Associated Factors</ET>
<AU>BEISKE (Antoine G.); HAVARD LOGE (Jon); HJERMSTAD (Marianne J.); SVENSSON (Elisabeth)</AU>
<AF>Department of Neurology, Akershus University Hospital/Norvège (1 aut.); Department of Oncology, National Resource Centre for Late Effects, Oslo University Hospital Montebello/Norvège (2 aut.); Department of Behavioural Sciences in Medicine, University of Oslo/Norvège (2 aut.); Department of Oncology, Regional Centre for Excellence in Palliative Care, Oslo University Hospital/Ulleval/Norvège (3 aut.); Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology/Norvège (3 aut.); Department of Adult Mental Health, Division of Mental Health, Norwegian Institute of Public Health/Norvège (4 aut.)</AF>
<DT>Publication en série; Courte communication, note brève; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2010; Vol. 25; No. 14; Pp. 2456-2460; Bibl. 29 ref.</SO>
<LA>Anglais</LA>
<EA>The purpose of this study was to examine the prevalence of fatigue in Parkinson's disease (PD) patients and compare this to the general population. Factors associated with fatigue were investigated by linear regression. Fatigue was assessed by the fatigue questionnaire. The mean age of the 176 PD patients (41 % women) was 69 years (range 35-90), and the mean UPDRSIII was 22.3 (SD 11.7). Fatigue levels (means) were significantly higher in PD patients compared with the general population; however, effect sizes were moderate for women for physical and total fatigue indicating clinically significant differences here only. Only female PD patients had more chronic fatigue than the general population. Fatigue was related to characteristics of PD but also to sleep disturbance, depression, and gender. This population-based study demonstrates that fatigue is a common symptom in PD patients, but compared with the general population, clinically significant differences were only found for female PD patients.</EA>
<CC>002B17; 002B17G</CC>
<FD>Maladie de Parkinson; Syndrome de fatigue chronique; Pathologie du système nerveux; Fatigue; Prévalence; Norvège</FD>
<FG>Europe; Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central</FG>
<ED>Parkinson disease; Chronic fatigue syndrome; Nervous system diseases; Fatigue; Prevalence; Norway</ED>
<EG>Europe; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease</EG>
<SD>Parkinson enfermedad; Fatiga crónica síndrome; Sistema nervioso patología; Fatiga; Prevalencia; Noruega</SD>
<LO>INIST-20953.354000192780100290</LO>
<ID>10-0491629</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000825 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000825 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:10-0491629 |texte= Fatigue in Parkinson's Disease: Prevalence and Associated Factors }}
This area was generated with Dilib version V0.6.23. |